Aclaris Therapeutics Inc (ACRS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ACRS? Forum Prognose

Finanzdaten der Aclaris Therapeutics Inc-Aktie (ACRS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	86.35% 2.398	17.57	9.282	1.869	2.528
Cost Of Revenue	11.59% 0.809	0.725	0.848	1.042	0.808
Gross Profit	90.57% 1.589	16.84	8.434	0.827	1.72
Operating Expenses	1.78% 20.52	20.89	40.01	32.64	31.64
Benefits Costs and Expenses	0.46% 19.34	19.43	40.86	33.68	30.69
Costs And Expenses	1.33% 21.33	21.62	40.86	33.68	32.45
Operating Income/Loss	367.78% -18.93	-4.047	-31.58	-31.82	-29.92
Income/Loss From Continuing Operations Before Tax	811.79% -16.94	-1.858	-31.58	-29.57	-28.16
Income Tax Expense/Benefit	100.00% -	-0.367	-	-	-
Income/Loss From Continuing Operations After Tax	1,036% -16.94	-1.491	-29.26	-29.57	-28.16
Net Income/Loss	1,036% -16.94	-1.491	-29.26	-29.57	-28.16
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	19,845% 71.07	0.3564	70.81	70.63	66.87
Diluted Average Shares	19,845% 71.07	0.3564	70.81	70.63	66.87
Basic Earnings Per Share	1,100% -0.24	-0.02	-0.41	-0.42	-0.42
Diluted Earnings Per Share	1,100% -0.24	-0.02	-0.41	-0.42	-0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

NTRA

$153.42

5.04%

$238.64

1.46%

ILMN

$130.74

3.19%

WAT

$355.47

0.83%

MTD

$1,174.56

0.43%

IDXX

$419.83

0.26%